U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938567) titled 'Preeclampsia Screening Trial to Improve Outcomes' on Oct. 14.
Brief Summary: The Pre-eclampsia Screening Trial to Improve Outcomes (PRESTO) research study aims to assess how clinicians use a blood test to guide care decisions in determining preeclampsia risk, with the overall aim of improving outcomes for both pregnant persons and their babies.
The study will evaluate whether a blood test can help doctors better identify pregnant patients with hypertensive disorders of pregnancy who are at risk of developing severe pre-eclampsia, which is a serious pregnancy condition that can affect organs such as the liver and kidneys and often l...